Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TTC9 |
| Upstream (Parents) |
|---|
| (<<) ACTB → TTC9 |
| (<<) ADAM9 → TTC9 |
| (<<) ANXA2 → TTC9 |
| (<<) BCL3 → TTC9 |
| (<<) CHAC1 → TTC9 |
| (<<) COL13A1 → TTC9 |
| (<<) KLK10 → TTC9 |
| (<<) MAFF → TTC9 |
| (<<) MAPK9 → TTC9 |
| (<<) RHOA → TTC9 |
| (<<) SP3 → TTC9 |
| (<<) TAGLN2 → TTC9 |
| (<<) TOP2B → TTC9 |
| (<<) VPS37B → TTC9 |
| (<<) YWHAQ → TTC9 |
| Downstream (Children) |
|---|
| TTC9 → ARSJ (>>) |
| TTC9 → CDKN2A (>>) |
| TTC9 → CLCF1 (>>) |
| TTC9 → DUSP6 (>>) |
| TTC9 → EPHA2 (>>) |
| TTC9 → IL23A (>>) |
| TTC9 → ISG20 (>>) |
| TTC9 → KRT16 (>>) |
| TTC9 → MLPH (>>) |
| TTC9 → PHLDA1 (>>) |
| TTC9 → PPP3CA (>>) |
| TTC9 → RCOR1 (>>) |
| TTC9 → SLC6A14 (>>) |
| TTC9 → SPRR3 (>>) |
